sur The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Stake in Avadel Pharmaceuticals
The Vanguard Group, Inc. has submitted a Form 8.3 disclosure under the Irish Takeover Panel Act, revealing its interests in Avadel Pharmaceuticals plc. According to the form, The Vanguard Group holds 5,565,939 ordinary shares, representing a 5.71% stake in Avadel Pharmaceuticals.
The announcement was made on November 24, 2025, detailing an opening position disclosure recorded on November 21, 2025. No additional parties to the offer were disclosed, and no cash-settled or stock-settled derivatives were reported.
The filing specifies that there are no indemnity or option arrangements related to the relevant securities. Furthermore, The Vanguard Group confirms the absence of agreements or arrangements associated with voting rights or future transactions of the securities mentioned.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de The Vanguard Group, Inc.